(Q40395117)

20 September 2017

title

Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia (English)

1 reference

20 September 2017

0 references

1 reference

Zibert A

1

1 reference

20 September 2017

Thomassen A

2

1 reference

20 September 2017

Müller L

3

1 reference

20 September 2017

Nguyen L

4

1 reference

20 September 2017

Glouchkova L

5

1 reference

20 September 2017

Fraefel C

6

1 reference

20 September 2017

Roskrow M

7

1 reference

20 September 2017

Meisel R

8

1 reference

20 September 2017

Dilloo D

9

1 reference

20 September 2017

publication date

1 December 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

12

1 reference

20 September 2017

issue

23

1 reference

20 September 2017

page(s)

1707-1717

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302577

20 September 2017

exact match

0 references

cites work

Therapeutic Gene Transfer to the Nervous System Using Viral Vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

HSV-1 amplicon vectors--simplicity and versatility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Gene therapy with B7.1 and GM-CSF vaccines in a murine AML model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Gene transfer of GM-CSF, CD80 and CD154 cDNA enhances survival in a murine model of acute leukemia with persistence of a minimal residual disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Herpes simplex inhibits the capacity of lymphoblastoid B cell lines to stimulate CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Deletion of the virion host shutoff protein (vhs) from herpes simplex virus (HSV) relieves the viral block to dendritic cell activation: potential of vhs- HSV vectors for dendritic cell-mediated immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

A viral inhibitor of peptide transporters for antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Cytolytic viruses as potential anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Chronic lymphocytic leukemia B cells are highly sensitive to infection by herpes simplex virus-1 via herpesvirus-entry-mediator A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Herpes simplex virus turns off the TAP to evade host immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

21 January 2018

T-cell clonal anergy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70 (CD27L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

An innate sense of danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Disabled infectious single-cycle herpes simplex virus as an oncolytic vector for immunotherapy of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Evidence that the herpes simplex virus immediate early protein ICP27 acts post-transcriptionally during infection to regulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Transfer of the nerve growth factor gene into cell lines and cultured neurons using a defective herpes simplex virus vector. Transfer of the NGF gene into cells by a HSV-1 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

CCL3/MIP-1alpha is a potent immunostimulator when coexpressed with interleukin-2 or granulocyte-macrophage colony-stimulating factor in a leukemia/lymphoma vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

Combined chemokine and cytokine gene transfer enhances antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

7 January 2021

Initial interaction of herpes simplex virus with cells is binding to heparan sulfate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

7 January 2021

An enhanced packaging system for helper-dependent herpes simplex virus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

7 January 2021

Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302577

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302577

1 reference

Dimensions Publication ID

20 September 2017

1022917099

0 references

1 reference